At the Benitec/Calimmune Sydney presentation the company said emphatically that they DO NOT intend to make and market any resulting drug! I got the impression that once there is data to prove the IP works the Board will be more interested in a Gillead type deal (see slide 16 of AGM presentation for some "they" and on that same page you'll find "what" could be a price.
Your off the mark with an IPO for Tacere.
Add to My Watchlist
What is My Watchlist?